111993 ⎘
Bacteriophages; Details dsDNA Bacteriophages; Myoviridae Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
PHAGE COMPOSITIONS FOR ESCHERICHIA COMPRISING CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF
#2BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS
#3BACTERIOPHAGE THERAPY AGAINST ADHERENT-INVASIVE ESCHERICHIA COLI
#4ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#5ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#6ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#7COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF PATHOGENIC ESCHERICHIA COLI
#8PHAGE THERAPY OF E COLI INFECTIONS
#9BACTERIOPHAGE THERAPY
#10Bacteriophage compositions and methods for treatment of bacterial infections
#11METHOD FOR PURIFICATION OF BACTERIOPHAGE PARTICLES
#12BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION
#13BACTERIOPHAGE COMPOSITIONS FOR TREATING CLOSTRIDIUM PERFRINGENS INFECTIONS
#14Bacteriophage compositions and methods for treatment of bacterial infections
#15Altering microbial populations and modifying microbiota
#16Bacteriophage and therapeutic agent for bacterial endophthalmitis
#17Antibacterial composition and uses thereof
#18NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS
#19MODIFIED BACTERIOPHAGE
#20PHAGE AND TRANSDUCTION PARTICLES
#21BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION
#22NOVEL BACTERIOPHAGE AND THERAPEUTIC AGENT FOR BACTERIAL ENDOPHTHALMITIS
#23Altering microbial populations and modifying microbiota
#24Altering microbial populations and modifying microbiota
#25ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#26BACTERIOPHAGE TREATMENT AND REDUCTION IN INFLAMMATORY RESPONSE
#27NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS
#28Method for purification of bacteriophage particles
#29THERAPEUTIC BACTERIOPHAGES
#30Bacteriophage therapy
#31Bacteriophage for treatment and prevention of and infections
#32BACTERIOPHAGE TREATMENT AND REDUCTION IN INFLAMMATORY RESPONSE
#33BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION
#34Compositions and methods for inhibiting the proliferation of pathogenic
#35Treatment of topical and systemic bacterial infections
#36E. COLI BACTERIOPHAGE ESC-COP-14 AND USE THEREOF IN INHIBITING GROWTH OF PATHOGENIC E. COLI
#37Phage therapy
#38Altering microbial populations and modifying microbiota
#39Vibrio parahaemolyticus bacteriophage Vib-PAP-7 and use of same for inhibiting vibrio parahaemolyticus bacteria proliferation
#40BACTERIOPHAGE COMPOSITIONS
#41bacteriophage Aer-HYP-3 and use thereof for inhibiting growth of bacteria
#42Phage therapy of infections
#43TREATMENT OF TOPICAL AND SYSTEMIC BACTERIAL INFECTIONS
#44Altering microbial populations and modifying microbiota
#45Bacteriophage strains and their applications
#46Altering microbial populations and modifying microbiota
#47PHAGE AND TRANSDUCTION PARTICLES
#48Bacteriophage and composition comprising same
#49Anti-bacterial compositions and uses thereof
#50TREATMENT OF TOPICAL AND SYSTEMIC BACTERIAL INFECTIONS
#51bacteriophage Esc-COP-7, and use thereof for suppressing proliferation of pathogenic
#52bacteriophage Vib-PAP-5 and use thereof for suppressing proliferation of bacteria
#53DNA, METHODS ETC
#54Bacteriophage and composition comprising same
#55BACTERIOPHAGE COMPOSITIONS AND USES THEREOF
#56Anti-bacterial compositions comparing lytic modified bacteriophage engineered to infect and kill different target bacteria
#57Composition comprising bacteriophages for reducing, eliminating and/or preventing , and B
#58Phage therapy of infections
#59bacteriophage Pas-MUP-1 and use thereof for inhibiting proliferation of
#60Bacteriophage compositions and methods of use thereof
#61Skin microbiome colonizer formulations and methods for use
#62Altering microbial populations and modifying microbiota
#63Lactococcus garvieae bacteriophage Lac-GAP-1 and use thereof in suppressing proliferation of lactococcus garvieae bacteria
#64Bacteriophage compositions and methods of selection of components against specific bacteria
#65Enteropathogenic bacteriophage Esc-CHP-2 and use thereof for inhibiting proliferation of enteropathogenic
#66Shigatoxin-producing F18 type bacteriophage esc-COP-1 and use thereof for inhibiting proliferation of shigatoxin-producing F18 type
#67Enteroinvasive bacteriophage Esc-COP-4 and use thereof for inhibiting proliferation of enteroinvasive
#68Enterohemorrhagic bacteriophage Esc-CHP-1 and use thereof for inhibiting proliferation of enterohemorrhagic
#69Phage therapy
#70PHAGE THERAPY FOR TARGETING ENTEROCOCCI
#71Altering microbial populations and modifying microbiota
#72A METHOD OF FEEDING AN ANIMAL TO IMPROVE GROWTH EFFICIENCY
#73Bacteriophage and composition comprising same
#74Bacteriophage and composition comprising same
#75Phage therapy of infections
#76Bacteriophages against ssp and their use
#77Phage therapy of pseudomonas infections
#78Bacteriophage therapy
#79Methods of using T4 bacteriophage in treatment of adenoviral infections caused by HAdV-5
#80Codon optimized recombinant phage and methods of using same
#81Bacteriophage for biocontrol of and in the manufacturing or processing of foods
#82Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development
#83PSEUDOMONAS AERUGINOSA BACTERIOPHAGE(S) AND USES THEREOF
#84ANTI-BACTERIA COMPOSITIONS
#85Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci
#86Purified bacteriophage, its preparation and application
#87Bacteriophage having killing activity specific to
#88Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water
#89IMMOBILISATION AND STABILISATION OF VIRUS
#90METHODS AND COMPOSITIONS INVOLVING BACTERIOPHAGE ISOLATES
#91BACTERIOPHAGES THAT INFECT BACILLUS BACTERIA (ANTHRAX)
#92Lysin-deficient bacteriophages having reduced immunogenicity
#93Immobilisation and stabilisation of virus
#94Recombinant K and 812 bacteriophages and uses thereof